PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8500529-3	1993	Here we show that for the human HLA-DRB1 and HLA-DRB3 gene products this ratio is controlled by the valine/glycine dimorphism at position 86.	Valine	100-106	major histocompatibility complex, class II, DR beta 1	Homo sapiens	32-40	
8500529-3	1993	Here we show that for the human HLA-DRB1 and HLA-DRB3 gene products this ratio is controlled by the valine/glycine dimorphism at position 86.	Valine	100-106	major histocompatibility complex, class II, DR beta 3	Homo sapiens	45-53	
8500529-3	1993	Here we show that for the human HLA-DRB1 and HLA-DRB3 gene products this ratio is controlled by the valine/glycine dimorphism at position 86.	Glycine	107-114	major histocompatibility complex, class II, DR beta 1	Homo sapiens	32-40	
8500529-3	1993	Here we show that for the human HLA-DRB1 and HLA-DRB3 gene products this ratio is controlled by the valine/glycine dimorphism at position 86.	Glycine	107-114	major histocompatibility complex, class II, DR beta 3	Homo sapiens	45-53	
8500529-6	1993	The valine/glycine dimorphism is highly conserved, present in most HLA-DR alleles and influences peptide-binding.	Valine	4-10	major histocompatibility complex, class II, DR beta 1	Homo sapiens	67-70	
8500529-6	1993	The valine/glycine dimorphism is highly conserved, present in most HLA-DR alleles and influences peptide-binding.	Glycine	11-18	major histocompatibility complex, class II, DR beta 1	Homo sapiens	67-70